GLP-1 medications, particularly those like BrightMeds, are rapidly gaining prominence in the treatment of type 2 diabetes and are increasingly explored for obesity . These powerful drugs help mimicking the body's natural incretin release, stimulating insulin production and curbing glucagon releas